Key result
High cumulative cholesterol-HDL-C-glucose index linked to ~78% higher risk of cardiometabolic multimorbidity.
Why the study?
Does higher cumulative exposure to the cholesterol-HDL-C-glucose index increase the risk of new-onset cardiometabolic multimorbidity in middle-aged and older adults?
Cohort (n=6,515)
Does higher cumulative exposure to the cholesterol-HDL-C-glucose index increase the risk of new-onset cardiometabolic multimorbidity in middle-aged and older adults?
Answers are grounded in this paper and cite their sources.
Cumulative exposure to a high cholesterol-HDL-C-glucose index is independently associated with an increased risk of new-onset cardiometabolic multimorbidity in middle-aged and older adults.
Background: The cholesterol-HDL-C-glucose (CHG) index has been proposed as an integrated marker of glucose-lipid metabolic dysfunction. However, the associations of long-term CHG exposure and its temporal patterns with new-onset cardiometabolic multimorbidity (CMM) remain unclear, particularly among middle-aged and older adults. Methods: We used data from the China Health and Retirement Longitudinal Study (CHARLS) and included participants aged 45 years or older without baseline CMM. Cumulative CHG (cuCHG) was calculated as a cumulative exposure metric based on CHG measured in 2012 and 2015. K-means clustering was applied to identify broad CHG patterns based on the two repeated measurements. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs), and restricted cubic spline (RCS) analyses were performed to examine the dose-response relationship. Results: Among 6,515 participants, 593 new-onset CMM events (9.1%) occurred over a median follow-up of 9 years. In the fully adjusted model, participants in the highest quartile of cuCHG had a 78% higher risk of new-onset CMM than those in the lowest quartile (HR 1.78, 95% CI 1.39-2.29), and each 1-unit increase in cuCHG was associated with a 23% higher risk (HR 1.23, 95% CI 1.15-1.32). Three distinct CHG patterns based on two repeated measurements were identified, and only the persistently high CHG pattern group was significantly associated with an increased risk of new-onset CMM (HR 2.05, 95% CI 1.61-2.61). RCS and piecewise Cox analyses suggested a non-linear association, with a potential threshold at a cuCHG value of 14.92. These findings remained robust across subgroup and sensitivity analyses. Compared with baseline CHG, the triglyceride-glucose index, and the atherogenic index of plasma, cuCHG and CHG pattern groups showed better discriminatory performance. Conclusions: Higher cumulative CHG exposure and a persistently high CHG pattern group were independently associated with an increased risk of new-onset CMM in middle-aged and older Chinese adults. Compared with a single baseline CHG measurement, cumulative CHG exposure and CHG patterns based on repeated measurements may provide additional information for CMM risk stratification.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a cohort in Cardiometabolic multimorbidity (n=6,515). Cumulative cholesterol-HDL-C-glucose (CHG) index vs. Lowest quartile of cumulative CHG was evaluated on New-onset cardiometabolic multimorbidity (HR 1.78, 95% CI 1.39-2.29). The highest quartile of cumulative cholesterol-HDL-C-glucose index exposure was associated with a 78% higher risk of new-onset cardiometabolic multimorbidity (HR 1.78; 95% CI 1.39-2.29).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: